tirzepatide and bone loss Tirzepatide: a novel therapeutic approach for Alzheimer's disease | Metabolic Brain Disease I kept seeing patients on

Alcohol consumption should be minimized or avoided, as it metabolizes unpredictably with tirzepatide and may amplify side effects

General symptoms such as persistent fatigue, dizziness (especially upon standing), excessive thirst, or decreased urine output may reflect dehydration and electrolyte depletion

Weight loss: In a phase 3 clinical trial , people with obesity taking tirzepatide lost an average of 15%21% of their body weight over 72 weeks (about a year and five months)

The Reason for Compassionate Use Compassionate use, or expanded access, exists for a reason

As insulin sensitivity improves, the body becomes more efficient at using stored fat for energy rather than storing excess glucose as abdominal fat

Monitoring trends Small weight fluctuations are normal